Showing 1 - 20 results of 21 for search 'Ewer, KJ', query time: 0.75s
Refine Results
-
1
Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies by Mugo, RM, Orindi, B, Shee, FM, Bellamy, D, Ewer, KJ, Bejon, P
Published 2023Journal article -
2
Efficacy and safety of a modified Vaccinia Ankara-NP+M1 vaccine combined with QIV in people aged 65 and older: a randomised controlled clinical trial (INVICTUS) by Butler, C, Ellis, C, Folegatti, P, Swayze, H, Allen, J, Lawrie, A, Yu, L, Shanyinde, M, Bellamy, D, Mair, C, Flaxman, A, Ewer, KJ, Gilbert, S
Published 2021Journal article -
3
CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination by Sharpe, HR, Provine, NM, Bowyer, GS, Moreira Folegatti, P, Belij-Rammerstorfer, S, Flaxman, A, Makinson, R, Hill, AV, Ewer, KJ, Pollard, AJ, Klenerman, P, Gilbert, S, Lambe, T
Published 2022Journal article -
4
Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies by Folegatti, P, Flaxman, A, Jenkin, D, Makinson, R, Kingham, L, Bellamy, D, Ramos Lopez, F, Sheridan, J, Poulton, I, Aboagye, J, Tran, N, Mitton, C, Roberts, R, Lawrie, A, Hill, A, Ewer, KJ, Gilbert, S
Published 2021Journal article -
5
A tool for evaluating heterogeneity in avidity of polyclonal antibodies by Li, K, Dodds, M, Spreng, RL, Abraha, M, Huntwork, RHC, Dahora, LC, Nyanhete, T, Dutta, S, Wille-Reece, U, Jongert, E, Ewer, KJ, Hill, AVS, Jin, C, Hill, J, Pollard, AJ, Munir Alam, S, Tomaras, GD, Dennison, SM
Published 2023Journal article -
6
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children by Tiono, AB, Nebie, I, Anagnostou, N, Coulibaly, AS, Bowyer, G, Lam, E, Bougouma, EC, Ouedraogo, A, Yaro, JBB, Barry, A, Roberts, R, Rampling, T, Bliss, C, Hodgson, S, Lawrie, A, Ouedraogo, A, Imoukhuede, EB, Ewer, KJ, Viebig, NK, Diarra, A, Leroy, O, Bejon, P, Hill, A, Sirima, SB
Published 2018Journal article -
7
High level efficacy in humans of a next-generation plasmodium falciparum anti-sporozoite vaccine: R21 in Matrix-M (TM) adjuvant by Venkatraman, N, Bowyer, G, Edwards, NJ, Griffiths, O, Powlson, J, Silman, D, Morter, R, Folegatti, PM, Minassian, AM, Poulton, ID, Collins, K, Brod, F, Angell-Manning, P, Berrie, E, Brendish, N, Glenn, G, Fries, L, Baum, J, Blagborough, AM, Roberts, R, Lawrie, AM, Lewis, DJ, Faust, SN, Gilbert, S, Ewer, KJ, Hill, AV
Published 2017Conference item -
8
Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal by Venkatraman, N, Ndiaye, B, Bowyer, G, Wade, D, Sridhar, S, Wright, D, Powlson, J, Ndiaye, I, Dièye, S, Thompson, C, Bakhoum, M, Morter, R, Capone, S, Del Sorbo, M, Jamieson, S, Rampling, T, Dattoo, M, Roberts, R, Poulton, I, Griffiths, O, Ballou, W, Roman, F, Lewis, DJM, Lawrie, A, Imoukhuede, E, Gilbert, S, Dieye, TN, Ewer, KJ, Hill, A, Mboup, S
Published 2018Journal article -
9
Evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals by Hodgson, SH, Ewer, KJ, Bliss, CM, Edwards, NJ, Rampling, T, Anagnostou, NA, De Barra, E, Havelock, T, Bowyer, G, Poulton, ID, De Cassan, S, Longley, R, Illingworth, JJ, Douglas, AD, Mange, PB, Collins, KA, Roberts, R, Gerry, S, Berrie, E, Moyle, S, Colloca, S, Cortese, R, Sinden, RE, Gilbert, SC, Bejon, P, Lawrie, AM, Nicosia, A, Faust, SN, Hill, AV
Published 2014Journal article -
10
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial by Datoo, MS, Dicko, A, Tinto, H, Ouédraogo, J-B, Hamaluba, M, Olotu, A, Beaumont, E, Ramos Lopez, F, Natama, HM, Weston, S, Chemba, M, Compaore, YD, Issiaka, D, Salou, D, Some, AM, Omenda, S, Lawrie, A, Bejon, P, Rao, H, Chandramohan, D, Roberts, R, Bharati, S, Stockdale, L, Gairola, S, Greenwood, BM, Ewer, KJ, Bradley, J, Kulkarni, PS, Shaligram, U, Hill, AVS
Published 2024Journal article -
11
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-... by Rampling, T, Ewer, KJ, Bowyer, G, Bliss, CM, Edwards, NJ, Wright, D, Payne, RO, Venkatraman, N, de Barra, E, Snudden, CM, Poulton, ID, de Graaf, H, Sukhtankar, P, Roberts, R, Ivinson, K, Weltzin, R, Rajkumar, BY, Wille-Reece, U, Lee, CK, Ockenhouse, CF, Sinden, RE, Gerry, S, Lawrie, AM, Vekemans, J, Morelle, D, Lievens, M, Ballou, RW, Cooke, GS, Faust, SN, Gilbert, S, Hill, AV
Published 2016Journal article -
12
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study by Schmit, N, Topazian, HM, Natama, HM, Bellamy, D, Traoré, O, Somé, MA, Rouamba, T, Tahita, MC, Bonko, MDA, Sourabié, A, Sorgho, H, Stockdale, L, Provstgaard-Morys, S, Aboagye, J, Woods, D, Rapi, K, Datoo, MS, Ramos Lopez, F, Charles, GD, McCain, K, Ouedraogo, J-B, Hamaluba, M, Olotu, A, Dicko, A, Tinto, H, Hill, AVS, Ewer, KJ, Ghani, AC, Winskill, P
Published 2024Journal article -
13
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four random... by Voysey, M, Costa Clemens, SA, Madhi, SA, Folegatti, PM, Aley, PK, Angus, B, Bibi, S, Cicconi, P, Clutterbuck, EA, Dold, C, Emary, KRW, Ewer, KJ, Flaxman, A, Feng, S, Green, CM, Greenland, M, Jenkin, D, Joe, CCD, Kerridge, S, Marchevsky, NG, Minassian, AM, Mujadidi, Y, Phillips, DJ, Plested, E, Ramasamy, M, Ritchie, AJ, Robinson, H, Song, R, Snape, MD, Douglas, AD, Hill, AVS, Lambe, T, Gilbert, SC, Pollard, AJ
Published 2021Journal article -
14
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial by Emary, KRW, Golubchik, T, Aley, PK, Angus, B, Bibi, S, Bonsall, D, Cicconi, P, Clutterbuck, EA, Dold, C, Douglas, AD, Ewer, KJ, Flaxman, AL, Feng, S, Folegatti, PM, Fuskova, M, Green, CM, Green, CA, Greenland, M, Jenkin, D, Kerridge, S, Marchevsky, NG, Minassian, AM, Mujadidi, YF, Phillips, DJ, Plested, E, Robinson, H, Song, R, Snape, MD, Hill, AVS, Lambe, T, Gilbert, SC, Voysey, M, Ramasamy, MN, Pollard, AJ, Et al.
Published 2021Journal article -
15
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial by Folegatti, PM, Ewer, KJ, Aley, PK, Angus, B, Becker, S, Belij-Rammerstorfer, S, Bellamy, D, Bibi, S, Bittaye, M, Clutterbuck, EA, Dold, C, Faust, SN, Finn, A, Flaxman, AL, Hallis, B, Heath, P, Jenkin, D, Lazarus, R, Makinson, R, Minassian, AM, Pollock, KM, Ramasamy, M, Robinson, H, Snape, M, Tarrant, R, Voysey, M, Green, C, Douglas, AD, Hill, AVS, Lambe, T, Gilbert, SC, Pollard, AJ, Oxford COVID Vaccine Trial Group
Published 2020Journal article -
16
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) by Flaxman, A, Marchevsky, NG, Jenkin, D, Aboagye, J, Aley, PK, Angus, B, Belij-Rammerstorfer, S, Bibi, S, Bittaye, M, Cappuccini, F, Cicconi, P, Clutterbuck, EA, Davies, S, Dejnirattisai, W, Dold, C, Ewer, KJ, Folegatti, PM, Fowler, J, Hill, AVS, Kerridge, S, Minassian, AM, Mongkolsapaya, J, Mujadidi, YF, Plested, E, Ramasamy, MN, Robinson, H, Sanders, H, Sheehan, E, Smith, H, Snape, MD, Song, R, Woods, D, Screaton, G, Gilbert, SC, Voysey, M, Pollard, AJ, Lambe, T
Published 2021Journal article -
17
Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP by Rampling, T, Ewer, KJ, Bowyer, G, Edwards, N, Wright, D, Sridhar, S, Payne, R, Powlson, J, Bliss, C, Venkatraman, N, Poulton, I, de Graaf, H, Gbesemete, D, Grobbelaar, A, Davis, H, Roberts, R, Angus, B, Ivinson, K, Weltzin, R, Rajkumar, B-Y, Wille-Reece, U, Lee, C, Ockenhouse, C, Sinden, R, Gerry, S, Lawrie, A, Vekemans, J, Morelle, D, Lievens, M, Ballou, RW, Lewis, DJM, Cooke, GS, Faust, SN, Gilbert, S, Hill, A
Published 2018Journal article -
18
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK by Voysey, M, Clemens, SAC, Madhi, SA, Weckx, LY, Folegatti, PM, Aley, PK, Angus, B, Baillie, VL, Barnabas, SL, Bhorat, QE, Bibi, S, Briner, C, Cicconi, P, Collins, AM, Colin-Jones, R, Cutland, CL, Darton, TC, Dheda, K, Duncan, CJA, Emary, KRW, Ewer, KJ, Fairlie, L, Faust, SN, Feng, S, Ferreira, DM, Finn, A, Goodman, AL, Green, CM, Green, CA, Heath, PT, Hill, C, Hill, H, Hirsch, I, Hodgson, SHC, Izu, A, Jackson, S, Jenkin, D, Joe, CCD, Kerridge, S, Koen, A, Kwatra, G, Lazarus, R, Lawrie, AM, Lelliott, A, Libri, V, Lillie, PJ, Mallory, R, Mendes, AVA, Milan, EP, Minassian, AM, Lambe, T, Pollard, AJ
Published 2020Journal article -
19
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses by Barrett, J, Belij-Rammerstorfer, S, Dold, C, Ewer, KJ, Folegatti, PM, Gilbride, C, Halkerston, R, Hill, J, Jenkin, D, Stockdale, L, Verheul, MK, Aley, PK, Angus, B, Bellamy, D, Berrie, E, Bibi, S, Bittaye, M, Carroll, MW, Cavell, B, Clutterbuck, EA, Edwards, N, Flaxman, A, Fuskova, M, Gorringe, A, Hallis, B, Kerridge, S, Lawrie, AM, Linder, A, Liu, X, Madhavan, M, Makinson, R, Mellors, J, Minassian, A, Moore, M, Mujadidi, Y, Plested, E, Poulton, I, Ramasamy, MN, Robinson, H, Rollier, CS, Song, R, Snape, MD, Tarrant, R, Taylor, S, Thomas, KM, Voysey, M, Watson, MEE, Wright, D, Douglas, AD, Green, CM, Hill, AVS, Lambe, T, Pollard, AJ
Published 2020Journal article -
20
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial by Ramasamy, MN, Minassian, AM, Ewer, KJ, Flaxman, AL, Folegatti, PM, Owens, DR, Voysey, M, Aley, PK, Angus, B, Babbage, G, Belij-Rammerstorfer, S, Berry, L, Bibi, S, Bittaye, M, Cathie, K, Chappell, H, Charlton, S, Cicconi, P, Clutterbuck, EA, Colin-Jones, R, Dold, C, Emary, KRW, Fedosyuk, S, Fuskova, M, Gbesemete, D, Green, C, Hallis, B, Hou, MM, Jenkin, D, Joe, CCD, Kelly, EJ, Kerridge, S, Lawrie, AM, Lelliott, A, Lwin, MN, Makinson, R, Marchevsky, NG, Mujadidi, Y, Munro, APS, Pacurar, M, Plested, E, Rand, J, Rawlinson, T, Rhead, S, Robinson, H, Ritchie, AJ, Ross-Russell, AL, Saich, S, Singh, N, Pollard, AJ, Oxford COVID Vaccine Trial Group
Published 2020Journal article